证券代码：688072 证券简称：拓荆科技 公告编号：2024-055 拓荆科技股份有限公司 关于向 2023 年限制性股票激励计划激励对象 授予预留部分限制性股票的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 限制性股票预留授予日：2024 年 11 月 14 日 限制性股票预留授予数量：111 万股（调整后，下同），约占拓荆科技股 份有限公司（以下简称"公司"）目前公司股本总额 27,832.0842 万股的 0.3988%。 股权激励方式：第二类限制性股票 公司《2023 年限制性股票激励计划（草案）》（以下简称"《激励计划》"） 规定的限制性股票预留授予条件已经成就，根据公司 2023 年第四次临时股东大 会授权，公司于 2024 年 11 月 14 日召开第二届董事会第九次会议及第二届监事 会第九次会议，审议通过了《关于公司向 2023 年限制性股票激励计划激励对象 授予预留部分限制性股票的议案》，确定 2024 年 11 月 14 日为预留授予日，以人 民币 94.36 元/股的授予价格 ...

拓荆科技股份有限公司监事会关于 （4）具有《公司法》规定的不得担任公司董事、高级管理人员情形的； （5）法律法规规定不得参与上市公司股权激励的； （6）中国证监会认定的其他情形。 1、本激励计划预留授予激励对象均不存在《管理办法》第八条规定的不得 成为激励对象的情形： （1）最近 12 个月内被证券交易所认定为不适当人选； （2）最近 12 个月内被中国证监会及其派出机构认定为不适当人选； （3）最近 12 个月内因重大违法违规行为被中国证监会及其派出机构行政处 罚或者采取市场禁入措施； 2、本激励计划预留授予激励对象不包括公司独立董事、监事、单独或合计 持有公司 5%以上股份的股东或实际控制人及其配偶、父母、子女。 2023 年限制性股票激励计划预留授予激励对象名单的核查意见 拓荆科技股份有限公司（以下简称"公司"）监事会依据《中华人民共和国 公司法》（以下简称"《公司法》"）、《中华人民共和国证券法》（以下简称"《证 券法》"）、《上市公司股权激励管理办法》（以下简称"《管理办法》"）、《上 海证券交易所科创板股票上市规则》（以下简称"《上市规则》"）、《科创板上 市公司自律监管指南第 4 号—股权激励信 ...

证券代码：688072 证券简称：拓荆科技 公告编号：2024-054 拓荆科技股份有限公司 关于调整 2023 年限制性股票激励计划相关事项的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 拓荆科技股份有限公司（以下简称"公司"）于 2024 年 11 月 14 日召开了 第二届董事会第九次会议及第二届监事会第九次会议，审议通过了《关于调整公 司 2023 年限制性股票激励计划相关事项的议案》。现将有关事项说明如下： 一、本次股权激励计划已履行的相关审批程序 1、2023 年 10 月 27 日，公司召开第一届董事会第二十八次会议，审议通过 了《关于公司<2023 年限制性股票激励计划（草案）>及其摘要的议案》《关于公 司<2023 年限制性股票激励计划实施考核管理办法>的议案》以及《关于提请公 司股东大会授权董事会办理股权激励相关事宜的议案》等议案。公司独立董事就 2023 年限制性股票激励计划（以下简称"本激励计划"）相关事项发表了同意的 独立意见。 同日，公司召开第一届监事会第十七次会议，审议通过了《关于公司 ...

证券代码：688072 证券简称：拓荆科技 公告编号：2024-053 拓荆科技股份有限公司 关于召开 2024 年第三季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 投资者可于 2024 年 11 月 18 日（星期一）至 11 月 22 日（星期五）16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 ir@piotech.cn 进行提问。公司将在说明会上对投资者普遍关注的问题进行回答。 拓荆科技股份有限公司（以下简称"公司"）已于 2024 年 10 月 29 日发布 公司 2024 年第三季度报告，为便于广大投资者更全面深入地了解公司 2024 年前 三季度经营成果、财务状况，公司计划于 2024 年 11 月 25 日上午 11:00-12:00 举 行 2024 年第三季度业绩说明会，在信息披露允许的范围内就投资者普遍关注的 问题进行回答。 一、 说明会类型 本次投资者说明会以网络文字互动问答形式召开，公司将针对 2024 年第三 季度的经营成果及财务指标的具体情况与 ...

北京市中伦律师事务所 关于拓荆科技股份有限公司 2023 年限制性股票激励计划调整及授予预留部分限制性 股票相关事项的 法律意见书 二〇二四年十一月 | 一、本次调整及本次授予的批准与授权 - - | 3 | | --- | --- | | 二、本次调整的相关情况 - - | 4 | | 三、本次授予的相关情况 - - | 5 | | 四、结论意见 - - | 7 | 北京市中伦律师事务所 关于拓荆科技股份有限公司 2023 年限制性股票激励计划调整及授予预留部分限制性股票相 关事项的 （2）本所及本所律师对本法律意见书所涉及的有关事实的了解，最终依赖 于公司向本所及本所律师提供的文件、资料及所作陈述，且公司已向本所及本 所律师作出如下保证：其已向本所律师提供的有关本激励计划以及出具本法律 意见书所需的所有法律文件和资料（包括但不限于原始书面材料、副本材料、 复印件或口头证言等）均是完整的、真实的、有效的，且已将全部事实向本所 律师披露，无任何隐瞒、遗漏、虚假或误导之处，其所提供的文件资料的副本 或复印件与正本或原件一致，且该等文件资料的签字与印章都是真实的，该等 文件的签署人业经合法授权并有效签署该等文件。 ...

Investment Rating - The investment rating for the company is maintained at "Accumulate-A" [1][4] Core Views - The company achieved record-high revenue in Q3 2024, with significant breakthroughs in new products and processes [1] - Revenue for Q3 2024 reached 1.011 billion yuan, representing a year-on-year increase of 44.67% and a quarter-on-quarter increase of 27.14% [1] - The company continues to benefit from high R&D investment, leading to breakthroughs in new products and processes validated by clients [1][4] Financial Performance - The company reported a net profit attributable to shareholders of 142 million yuan in Q3 2024, a decrease of 2.91% year-on-year but an increase of 19.87% quarter-on-quarter [1] - The gross profit margin for Q3 2024 was 39.27%, down 12.40 percentage points year-on-year and 7.62 percentage points quarter-on-quarter, primarily due to the high costs associated with new products and processes [1] - The company expects revenues of 3.870 billion, 5.250 billion, and 6.615 billion yuan for 2024, 2025, and 2026 respectively, with growth rates of 43.1%, 35.6%, and 26.0% [4][5] Product Development - The company has achieved full coverage of PECVD dielectric film materials, with multiple new products in mass production [4] - New equipment platforms (PF-300M and PF-300T Plus) and new reaction chambers (Supra-D) have been developed and are receiving orders from multiple clients [1][3] - The company’s SACVD equipment has seen increased application in domestic integrated circuit manufacturing lines [1][3] Market Position - The company’s equipment performance and capacity have reached international leading levels, with significant orders and repeat orders from clients [1][3] - The company is well-positioned to benefit from the rapid development of advanced packaging technologies [4]

Investment Rating - The investment rating for the company is "Outperform the Market" [3][9]. Core Views - The company has achieved a revenue growth of 33.79% year-on-year in the first three quarters, with total revenue reaching 2.278 billion yuan and a net profit of 271 million yuan, reflecting a slight increase of 0.1% year-on-year [1]. - The third quarter saw a significant revenue increase of 44.67% year-on-year, amounting to 1.011 billion yuan, although net profit decreased by 2.74% year-on-year [1]. - The company's gross margin has decreased to 43.59%, down 6.75 percentage points year-on-year, primarily due to the high costs associated with the validation of new products and processes [1]. - The company continues to invest heavily in research and development, with R&D expenses increasing by 35.75% year-on-year to 481 million yuan [1]. Financial Summary - Revenue projections for 2024-2026 are adjusted to 3.809 billion yuan, 5.170 billion yuan, and 6.635 billion yuan, respectively, with corresponding net profit estimates of 552 million yuan, 916 million yuan, and 1.230 billion yuan [1][2]. - The company's earnings per share (EPS) for 2024 is projected at 1.98 yuan, with a price-to-earnings (P/E) ratio of 78.2 [2][7]. - The gross margin for the third quarter was reported at 39.27%, reflecting a quarter-on-quarter decline of 7.62 percentage points [1][5].

Investment Rating - The investment rating for the company is "Buy" and it is maintained [5]. Core Insights - The company reported a revenue of 1.011 billion yuan in Q3 2024, representing a year-on-year increase of 44.67%. However, the net profit attributable to the parent company decreased by 2.91% to 142 million yuan, and the net profit after deducting non-recurring gains and losses fell by 58.79% to 46 million yuan. The gross margin was 39.27%, down 12.4 percentage points year-on-year [5][6]. - For the first three quarters of 2024, the company achieved a revenue of 2.278 billion yuan, an increase of 33.79% year-on-year, with a net profit attributable to the parent company of 271 million yuan, a slight increase of 0.10%. The net profit after deducting non-recurring gains and losses was 65 million yuan, down 62.72%, and the gross margin was 43.59%, down 6.8 percentage points year-on-year [5][6]. Summary by Sections R&D and Product Development - The company has significantly increased its R&D investment, reaching 480 million yuan in the first three quarters of 2024, a year-on-year growth of approximately 36%, accounting for 21.1% of revenue, which is an increase of 0.3 percentage points. This investment is aimed at expanding new products and processes, as well as optimizing equipment platforms and reaction chambers [5][6]. - The introduction of new products and processes has led to a temporary decline in gross margin due to higher costs during the customer validation phase. However, as these new products achieve scale, the gross margin is expected to stabilize and recover [5][6]. Order Growth and Market Position - The company has seen strong order growth, with its main product PECVD and other products like ALD, SACVD, and HDPCVD contributing to increased orders. The company has upgraded its HDPCVD product to a new hexagonal platform, achieving industry-leading performance [6]. - As of August 2024, the cumulative installation of reaction chambers exceeded 70 units, with expectations to surpass 100 units by the end of 2024. The company is well-positioned to benefit from domestic substitution trends and downstream capacity expansion, leading to sustained high growth in orders and performance [6]. Financial Projections - The company is projected to achieve net profits of 540 million yuan, 970 million yuan, and 1.36 billion yuan for the years 2024, 2025, and 2026, respectively. The corresponding price-to-earnings ratios are expected to be 79x, 43x, and 31x [6].

Investment Rating - The report maintains a rating of "Buy" for the company [1]. Core Views - The company has accelerated the pace of new product acceptance, leading to a quarter-on-quarter revenue increase of 27% in Q3 2024, although gross margins are under short-term pressure due to new product impacts [1][2]. - For the first three quarters of 2024, the company reported revenue of 2.278 billion yuan, a year-on-year increase of 33.79%, while net profit attributable to shareholders was 271 million yuan, showing a slight year-on-year growth of 0.10% [4][5]. Financial Summary - **Revenue (Million Yuan)**: - 2022A: 1,706 - 2023A: 2,705 - 2024E: 3,855 - 2025E: 5,057 - 2026E: 6,426 - **Year-on-Year Growth Rate (%)**: - 2022A: 125.0 - 2023A: 58.6 - 2024E: 42.5 - 2025E: 31.2 - 2026E: 27.1 [1][10]. - **Net Profit (Million Yuan)**: - 2022A: 368 - 2023A: 663 - 2024E: 664 - 2025E: 963 - 2026E: 1,331 - **Year-on-Year Growth Rate (%)**: - 2022A: 438.0 - 2023A: 79.8 - 2024E: 0.2 - 2025E: 45.0 - 2026E: 38.3 [1][10]. - **Key Financial Ratios**: - ROE (%): - 2022A: 9.8 - 2023A: 14.5 - 2024E: 12.8 - 2025E: 15.9 - 2026E: 18.2 [1][10]. - **Earnings Per Share (Latest Diluted)**: - 2022A: 1.32 - 2023A: 2.38 - 2024E: 2.39 - 2025E: 3.46 - 2026E: 4.78 [1][10]. Quarterly Financial Performance - In Q3 2024, the company achieved a revenue of 1.011 billion yuan, representing a quarter-on-quarter growth of 27.14%, with a net profit of 142 million yuan, reflecting a quarter-on-quarter increase of 19.87% [2][3]. - The gross margin for Q3 2024 was reported at 39.27%, down 7.62 percentage points from the previous quarter, indicating a temporary decline due to new product impacts [2][3].